twitter twitter

Bio Ascend

Ultmann Chicago Lymphoma Symposium Agenda

Faculty slides approved for release are now available.

Day 1 - Friday, April 21
Day 2 - Saturday, April 22

Component 1

Download Presentation

Layer 1

Watch Video

Component 1

Download Presentation

Layer 1

Watch Video

Interprofessional Session

Welcome, Introductions, and Pre-session ARS

Morning Session #1

Bispecific Antibodies in Follicular LymphomaJulie Pruett, APNP
CAR T-Cells and Target agents in Follicular LymphomaTalha Khan, PharmD, BCOP
Audience Q&A
Sexual Health in the AYA Patient PopulationAdam Duvall, MD, MPH
Audience Q&A and Post-session ARS
Break & Exhibits

Morning Session #2: How Would You Treat?

Pre-session ARS
Treatment Landscape in DLBCLTara McCabe, APN
Component 1
Layer 1
DLBCL Patient Case StudiesTara McCabe, APN and Rebecca Rosenbloom, RN, BSN
Panel discussion and Q&A
Treatment Landscape in CLL Jennifer Boyer Greenfield, MSN, APRN, NP-C
CLL Patient Case StudiesJennifer Boyer Greenfield, MSN, APRN, NP-C – Bianca Campanile, RN – Rachel Kraft, MSN, RN
Panel discussion, Q&A, and Post-session ARS
Session Wrap-Up

General Session

Welcome and Introductions

Mini Symposium on Biology of Lymphoma and the Immune Microenvironment

Pre-session ARS
From Cell of Origin to Mutational LandscapeLaura Hilton, PhD
Targeting Epigenetics – How Far Have We Come?Ari Melnick, MD
Immune Microenvironment of LymphomaStephen Ansell, MD, PhD
Panel discussion. Q&A and Post-session ARS

Break & Exhibits

Keynote Presentation: Evolution in the Classification of Lymphoma: From WHO to ICCWhere Do We Go From Here?
Mini Symposium on Imaging and ctDNA in Lymphoma
How Many Scans Are Too Many?Carrie Thompson, MD

Are We Ready to Move Beyond Standard Imaging for Surveillance? MTV and Radiomics – Maryellen Giger, PhD

Are We Ready to Move Beyond Standard Imaging for Surveillance? ctDNA – Mark Roschewski, MD

Panel discussion, Q&A, and Post-session ARS

General Session Wrap-up

Welcome Reception with Exhibitors

Component 1

Download Presentation

Layer 1

Watch Video

Component 1

Download Presentation

Layer 1

Watch Video

General Session

Welcome and Introductions

Practical Strategies for Diversity, Equity, and Inclusion in Clinical Lymphoma Research - Ruemu Birhiray, MD

Mini Symposium on Hodgkin Lymphoma
Pre-session ARS
Frontline Approaches for Previously Untreated HLJonathan Friedberg, MD, MMSc
Treating Relapsed/Refractory HL Ann LaCasce, MD, MMSc
Caring for Older/Comorbid Patients With HLAndrew Evens, DO, MBA, MSc
Panel discussion, Q&A, and Post-session ARS

Break & Exhibits

20 Years of IUCLS
Pre-session ARS
A Look Back at 20 Years of IUCLS

“Dual” Keynote Symposium: A Look at the Advancement of Lymphoma Therapy Over the Last 20 Years

  • The Evolution of Novel Therapies in MCLMichael Williams, MD 
  • Incorporation of Bispecific Antibodies into Lymphoma Therapy – Nancy Bartlett, MD 

“Dual” Keynote Symposium: Experts Debate the Role of Transplant in PTCL

  • Pro Barbara Pro, MD / ConRanjana Advani, MD
Panel discussion, Q&A, and Post-session ARS

Lunch, Exhibits, and Meet the Professor Session

Mini Symposium on Transplant and Cellular Therapy
Pre-session ARS

DEBATE: CAR T-cell Therapy Should be Standard Therapy For All Patients with Early Relapsed DLBCL

  • Pro TransplantTimothy Fenske, MD, MS | Pro CAR TJeremy Abramson, MD 
Resistance to Cellular TherapyCatherine Bollard, MD, MBChB
Panel discussion, Q&A, and Post-session ARS

Break & Exhibits

Mini Symposium on Follicular Lymphoma
Panel discussion, Q&A, and Post-session ARS
Historical Perspectives of FLLeo Gordon, MD
Future Directions in the Treatment of FLBrad Kahl, MD
Current Gaps of TreatmentLoretta Nastoupil, MD
Panel discussion, Q&A, and Post-session ARS
Summary and Best of IUCLSCLS Chairs
Adjourn

Time (CST)

Friday, April 21

1:00 PM – 1:05 PM

Welcome and Introductions

1:05 PM – 2:30 PM

Mini Symposium on Biology of Lymphoma and the Immune Microenvironment

1:05 – 1:10 PM Pre-session ARS

1:10 – 1:30 PM: From Cell of Origin to Mutational Landscape
David Scott, MBChB PhD

1:30 – 1:50 PM: Molecular Monitoring of Lymphoma with ctDNA

1:50 – 2:10 PM: Immune Microenvironment of Lymphoma
Stephen Ansell, MD, PhD

2:10 – 2:30 PM: Panel discussion, Q&A, and Post-session ARS

2:30 PM – 2:50 PM

Break & Exhibits

2:50PM – 5:00 PM

Mini Symposium on Classification and Imaging in Lymphoma

2:50 – 3:50 PM: Keynote: Evolution in the Classification of Lymphoma: From WHO to ICC – Where do we go from here?

3:50 – 4:30 PM: PET Imaging in Lymphoma

  • 3:50 – 4:10 PM: Historical Perspectives
  • 4:10 – 4:30 PM: Future Directions
 

4:30 – 4:50 PM: How Many Scans are Too Many?
Carrie Thompson, MD, MS

4:50 – 5:10 PM: Panel discussion, Q&A, and Post-session ARS

5:10 PM

General Session Wrap Up and Summary

Time (CST)

Saturday, April 22

8:00 AM – 8:05 AM

Welcome and Introductions

8:00 AM – 8:25 AM

Practical Strategies for Diversity, Equity, and Inclusion in Clinical Lymphoma Research
Ruemu Birhiray, MD

8:25 AM – 9:50 AM

Mini Symposium on Hodgkin Lymphoma

8:25 – 8:30 AM: Pre-session ARS

8:35 – 8:55 AM: Frontline Approaches for Previously Untreated HL
Jonathan Friedberg, MD, MMSc

8:55 – 9:15 AM: Treating Relapsed/Refractory HL
Ann LaCasce, MD, MMSc

9:15 – 9:35 AM: Caring for Older/Comorbid Patients with HL
Andrew Evens, DO, MBA, MSc

9:35 – 9:50 AM: Panel discussion with speakers, Q&A, and post-session ARS

9:50 AM – 10:10 AM

Break & Virtual Exhibit

10:10 AM – 12:00 PM

20 Years of IUCLS

10:10 – 10:15 AM: Pre-session ARS

10:15 – 10:35 AM: A Look Back at 20 Years of IUCLS

10:35 – 11:15 AM: “Dual” Keynote Symposium: A Look at the Advancement of Lymphoma Therapy Over the Last 20 Years

  • The Evolution of Novel Therapies in MCL
    Michael Williams, MD
  • Incorporation of Bispecific Antibodies into Lymphoma Therapy
    Nancy Bartlett, MD

11:15 – 11:55 AM: “Duel” Keynote Symposium: Experts Debate the Role of Transplant in PTCL

  • Pro
  • Con – Ranjana Advani, MD


11:55 AM – 12:00 PM: Panel discussion, Q&A, and Post-session ARS

12:00 PM – 1:00 PM

Lunch & Exhibits

1:00 PM – 2:25 PM

Mini Symposium on Transplant and Cellular Therapy

1:00 – 1:05 PM: Pre-session ARS

1:05 – 1:25 PM: Where do Auto and Allo SCT Have a Role in Lymphoid Malignancies?

1:25 – 1:45 PM: Sequencing of CAR T-cell Therapy

1:45 – 2:05 PM: Resistance to Cellular Therapy
Catherine Bollard, MD, MBChB

2:05 – 2:25 PM: Panel discussion with speakers, Q&A, and post-session ARS

2:25 PM – 2:45 PM

Break & Virtual Exhibits

2:45 PM – 4:10 PM

Mini Symposium on Follicular Lymphoma

2:45 – 2:50 PM: Pre-session ARS

2:50 – 3:10 PM: Historical Perspectives of FL
Leo Gordon, MD

3:10 –3:30 PM: Future Directions in the Treatment of FL
Brad Kahl, MD

3:30 – 3:50 PM: Current Gaps of Treatment
Loretta Nastoupil, MD

3:50 – 4:10 PM: Panel discussion, Q&A, and Post-session ARS

4:10 – 4:30PM

Summary and Best of IUCLS

4:30 PM

Adjourn

This website uses cookies to ensure you get the best experience on our website.